Kimberley Brantley-Hite

Kimberley Brantley-Hite serves as an Adjunct Assistant Professor in the Department of Pharmacy Practice and Science at the University of Kentucky College of Pharmacy while holding the executive position of Senior Director of Medication Safety Outcomes and Value at UK Healthcare. In this dual capacity, she provides strategic oversight for pharmacy value analytics, medication safety systems, drug diversion surveillance, and enterprise-wide accreditation preparedness, additionally functioning as pharmacy lead for the Pharmacy & Therapeutics committee.

Dr. Brantley-Hite's educational foundation includes:

• Bachelor of Science in Pharmacy from The Ohio State University (1987)
• Master of Science in Hospital and Clinical Pharmacy from The Ohio State University (1989)
• PGY1 & PGY2 Pharmacy Practice Residency at The Ohio State University Hospital
• Doctor of Pharmacy from the University of Kentucky (1999)

Her research program centers on Medication Safety and Pharmacoeconomics, with significant contributions to Healthcare Analytics and Pharmacy Informatics. Current work focuses on optimizing medication use systems through value-based analytics, accreditation compliance frameworks, and surveillance protocols for drug diversion prevention. Her expertise extends to sterile compounding standards as evidenced by USP Chapter 797 implementation research.

Analysis of her publication record reveals early leadership in medication safety informatics, particularly through 2006 studies examining computerized practitioner order entry impacts on error reporting and standardized training for sterile compounding. These works established foundational methodologies connecting health information technology with pharmaceutical outcomes measurement, reflecting her enduring focus on evidence-based medication management systems.

No information regarding student mentorship or research grant funding was documented in available sources.

As Senior Director, Dr. Brantley-Hite leads cross-functional teams across UK Healthcare's medication safety enterprise, directing analytics units, policy development groups, and the Pharmacy & Therapeutics committee's evidence review processes. Her operational structure integrates clinical pharmacy services with institutional quality improvement initiatives through centralized medication safety oversight.